V018-5415 Screening compound: 3-(1-{5-benzyl-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide

V018-5415 Screening compound: 3-(1-{5-benzyl-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide
V018-5415 Screening compound: 3-(1-{5-benzyl-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V018-5415
3-(1-{5-benzyl-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V018-5415

Molecular Formula

C25H33N5O3 (C25 H33 N5 O3)

Compound Name

3-(1-{5-benzyl-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide

IUPAC name

3-(1-{5-benzyl-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepin-2-yl}-N-(2-methylpropyl)formamido)-N-cyclopropylpropanamide

SMILES

CC(C)CN(CCC(NC1CC1)=O)C(c1nn(CCCN(Cc2ccccc2)C2=O)c2c1)=O

InChI

InChI=1S/C25H33N5O3/c1-18(2)16-29(14-11-23(31)26-20-9-10-20)24(32)21-15-22-25(33)28(12-6-13-30(22)27-21)17-19-7-4-3-5-8-19/h3-5,7-8,15,18,20H,6,9-14,16-17H2,1-2H3,(H,26,31)

InChI Key

NNJMRYLLHVEXJI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19907786

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

451.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.185

Distribution Coefficient, logD

2.185

Water Solubility, LogSw

-2.77

Polar Surface Area

71.099

Acid Dissociation Constant (pKa)

13.58

Base Dissociation Constant (pKb)

-0.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.00

V018-5415 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with V018-5415 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V018-5415?
Check Price and Availability of V018-5415, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V018-5415 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V018-5415
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V018-5415
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V018-5415 available by request